Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)

Salawu, A; Demicco, E; Chung, PWM; Feeney, J; Spickard, E; Rathore, R; Lee, J; Wong, P; Malone, ER; Catton, C; Arones, L; Phillips, MJ; Ferguson, PC; Wunder, J; Tin, T; Sethi, H; Liu, MC; Shultz, DB; Razak, ARA

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):